Precursors / Herceptin, Roche, Mississauga
Herceptin, Roche, Mississauga
Cited as ON
- Syntheses citing them
- 4
- Distinct agents
- 4
- Distinct precursors
- 4
From the literature
Precursors named in the literature
Names as written by the authors. Grade, packaging and current availability are not published and have to be confirmed with the supplier.
Where they were used
| Agent | Precursor | Module | Purification | Source |
|---|---|---|---|---|
| [225Ac]Ac-DOTA-trastuzumab | DOTA-trastuzumab IgG | Manual synthesis | — | 39666273 2025 Mol Pharm |
| [18F]Dolutegravir | 2-fluoro-4-nitrobenzonitrile | TRACERlab FX N Pro | HPLC+SPE | 35631413 2022 Pharmaceuticals (Basel) |
| [131I]I-T-ZHP1 | T-ZHP1 (trastuzumab-ZHP1 conjugate) | Manual synthesis | SPE | 33247180 2020 Sci Rep |
| [213Bi]Bi-anti-CD20 | anti-CD20 antibody (Rituximab, MabThera) | Manual synthesis | SPE | 23474846 2013 Oncotarget |
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from Herceptin, Roche, Mississauga itself.
Need this precursor?We can point you to suppliers for Herceptin, Roche, Mississauga, or handle the enquiry for you.
Get in touch